| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adolescents and young adults with cancer and the risk of subsequent primary neoplasms: not just big children
|
Gupta, Sumit
|
|
2019
|
20 |
4 |
p. 466-467
|
artikel
|
| 2 |
Artificial intelligence, chatbots, and the future of medicine
|
Greene, Alan
|
|
2019
|
20 |
4 |
p. 481-482
|
artikel
|
| 3 |
Assessment of breast cancer risk: which tools to use?
|
Garcia-Closas, Montserrat
|
|
2019
|
20 |
4 |
p. 463-464
|
artikel
|
| 4 |
A well organised effort to metastatic non-clear-cell renal cell carcinoma
|
Russo, Paul
|
|
2019
|
20 |
4 |
p. 472-473
|
artikel
|
| 5 |
Brexit, radiology, and NHS privatisation: a tragedy for frontline care?
|
The Lancet Oncology,
|
|
2019
|
20 |
4 |
p. 459
|
artikel
|
| 6 |
Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study
|
Martínez Chanzá, Nieves
|
|
2019
|
20 |
4 |
p. 581-590
|
artikel
|
| 7 |
CHISELing a path forward in the treatment of early-stage non-small-cell lung cancer
|
AlShafa, Faiez
|
|
2019
|
20 |
4 |
p. 461-463
|
artikel
|
| 8 |
Choosing Wisely India: ten low-value or harmful practices that should be avoided in cancer care
|
Pramesh, C S
|
|
2019
|
20 |
4 |
p. e218-e223
|
artikel
|
| 9 |
Diagnostic accuracy and safety of 16α-[18F]fluoro-17β-oestradiol PET-CT for the assessment of oestrogen receptor status in recurrent or metastatic lesions in patients with breast cancer: a prospective cohort study
|
Chae, Sun Young
|
|
2019
|
20 |
4 |
p. 546-555
|
artikel
|
| 10 |
Dose recommendations for anticancer drugs in patients with renal or hepatic impairment
|
Krens, Stefanie D
|
|
2019
|
20 |
4 |
p. e200-e207
|
artikel
|
| 11 |
Effective and well tolerated: where do these drugs fit now?
|
Duchesne, Gillian M
|
|
2019
|
20 |
4 |
p. 469-470
|
artikel
|
| 12 |
ESMO-MCBS: setting the record straight
|
Cherny, Nathan I
|
|
2019
|
20 |
4 |
p. e192
|
artikel
|
| 13 |
ESMO-MCBS: setting the record straight – Authors' reply
|
Lievens, Yolande
|
|
2019
|
20 |
4 |
p. e193
|
artikel
|
| 14 |
Estimating the total incidence of global childhood cancer: a simulation-based analysis
|
Ward, Zachary J
|
|
2019
|
20 |
4 |
p. 483-493
|
artikel
|
| 15 |
Extending the scope of PARP inhibitors in ovarian cancer
|
Ledermann, Jonathan A
|
|
2019
|
20 |
4 |
p. 470-472
|
artikel
|
| 16 |
How can global incidence estimates support childhood cancer control?
|
Steliarova-Foucher, Eva
|
|
2019
|
20 |
4 |
p. 460-461
|
artikel
|
| 17 |
Interactive architecture—UV protection unfolding above you!
|
Kapelos, George Thomas
|
|
2019
|
20 |
4 |
p. 479-480
|
artikel
|
| 18 |
Malignant priapism and germ cell tumour
|
Lam, Ka On
|
|
2019
|
20 |
4 |
p. e224
|
artikel
|
| 19 |
Neratinib and capecitabine for breast cancer brain metastases
|
Stirrups, Robert
|
|
2019
|
20 |
4 |
p. e197
|
artikel
|
| 20 |
New prognostic model for prostate cancer
|
Gourd, Elizabeth
|
|
2019
|
20 |
4 |
p. e198
|
artikel
|
| 21 |
No benefit of lymphadenectomy for advanced ovarian cancer
|
Gourd, Elizabeth
|
|
2019
|
20 |
4 |
p. e195
|
artikel
|
| 22 |
Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial
|
Konstantinopoulos, Panagiotis A
|
|
2019
|
20 |
4 |
p. 570-580
|
artikel
|
| 23 |
Patient-reported outcomes following enzalutamide or placebo in men with non-metastatic, castration-resistant prostate cancer (PROSPER): a multicentre, randomised, double-blind, phase 3 trial
|
Tombal, Bertrand
|
|
2019
|
20 |
4 |
p. 556-569
|
artikel
|
| 24 |
Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study
|
Meric-Bernstam, Funda
|
|
2019
|
20 |
4 |
p. 518-530
|
artikel
|
| 25 |
PET-guided, BEACOPPescalated therapy in advanced Hodgkin lymphoma
|
Mesguich, Charles
|
|
2019
|
20 |
4 |
p. e189
|
artikel
|
| 26 |
PET-guided, BEACOPPescalated therapy in advanced Hodgkin lymphoma
|
Reid, Justin H
|
|
2019
|
20 |
4 |
p. e188
|
artikel
|
| 27 |
PET-guided, BEACOPPescalated therapy in advanced Hodgkin lymphoma – Authors' reply
|
Casasnovas, René-Olivier
|
|
2019
|
20 |
4 |
p. e190
|
artikel
|
| 28 |
PET oestrogen receptor imaging: ready for the clinic?
|
Mankoff, David A
|
|
2019
|
20 |
4 |
p. 467-469
|
artikel
|
| 29 |
Precision oncology giveth and precision oncology taketh away
|
Saltz, Leonard B
|
|
2019
|
20 |
4 |
p. 464-466
|
artikel
|
| 30 |
Predicting recurrence in patients with localised renal cell carcinoma after nephrectomy
|
Lotan, Yair
|
|
2019
|
20 |
4 |
p. 473-475
|
artikel
|
| 31 |
Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study
|
Wei, Jin-Huan
|
|
2019
|
20 |
4 |
p. 591-600
|
artikel
|
| 32 |
Preference-based intervention in prostate cancer
|
Das, Manjulika
|
|
2019
|
20 |
4 |
p. e199
|
artikel
|
| 33 |
Ramucirumab in advanced hepatocellular carcinoma in REACH-2: the true value of α-fetoprotein
|
Zhu, Andrew X
|
|
2019
|
20 |
4 |
p. e191
|
artikel
|
| 34 |
Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): a population-based, cohort study
|
Bright, Chloe J
|
|
2019
|
20 |
4 |
p. 531-545
|
artikel
|
| 35 |
Sacituzumab govitecan-hziy for triple-negative breast cancer
|
Stirrups, Robert
|
|
2019
|
20 |
4 |
p. e194
|
artikel
|
| 36 |
Smokeless tobacco control in 180 countries across the globe: call to action for full implementation of WHO FCTC measures
|
Mehrotra, Ravi
|
|
2019
|
20 |
4 |
p. e208-e217
|
artikel
|
| 37 |
Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial
|
Ball, David
|
|
2019
|
20 |
4 |
p. 494-503
|
artikel
|
| 38 |
Surufatinib in neuroendocrine tumours
|
Das, Manjulika
|
|
2019
|
20 |
4 |
p. e196
|
artikel
|
| 39 |
Tobacco consumption in Bangladesh
|
Burki, Talha Khan
|
|
2019
|
20 |
4 |
p. 478
|
artikel
|
| 40 |
Use of medical cannabis: perceptions of Israeli oncologists
|
Mirelman, Dan
|
|
2019
|
20 |
4 |
p. 475-477
|
artikel
|
| 41 |
10-year performance of four models of breast cancer risk: a validation study
|
Terry, Mary Beth
|
|
2019
|
20 |
4 |
p. 504-517
|
artikel
|
Tijdschrift beschrijving